MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-01-0002214
Solvista Pharma Private Limited - chemicals in Ambala Cantt, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹21.06 Lakh
▼ 32% YoY
Net loss · FY 2023
₹4.14 Lakh
Net margin -19.7%
EBITDA · FY 2023
-₹3.11 Lakh
EBITDA margin -14.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Solvista Pharma Private Limited
Data last updated:
Solvista Pharma Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24234HR2016PTC057908. Its GSTIN is 06AAXCS3424J1ZW (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anjana Malhotra and Prerna Sharma.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 99/5 Ram Nagar Near Janki Marbels, Ambala Cantt, Haryana, India – 134003.
As per the financials filed for FY 2023, the company reported a revenue of ₹21.06 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹4.14 Lakh (net margin -19.7%) and EBITDA of -₹3.11 Lakh (EBITDA margin -14.8%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 15% over five years.
Solvista Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0002214). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website solvistapharma.org.
Company details
CIN U24234HR2016PTC057908
Registration Number 057908
Incorporation Date 21 January 2016
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-01-0002214
Key People
Anjana Malhotra Director Prerna Sharma Director Recognitions & Rankings of Solvista Pharma
Contact details
Solvista Pharma Private Limited's registered office is in Ambala Cantt, Haryana. Its website is solvistapharma.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address99/5 Ram Nagar Near Janki Marbels, Ambala Cantt, Haryana, India – 134003
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Solvista Pharma Private Limited, buy the company report.
Comprehensive company report
Solvista Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Solvista Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Solvista Pharma Private Limited, buy the company report.
Financials of Solvista Pharma Private Limited
FY 2023 filings availableSolvista Pharma Private Limited reported revenue of ₹21.06 Lakh (down 32% YoY) for FY 2023.
Revenue · FY 2023
₹21.06 Lakh ▼ 32%
Net loss · FY 2023
₹4.14 Lakh margin -19.7%
EBITDA · FY 2023
-₹3.11 Lakh margin -14.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 7%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▼ 703%
3 years · compounded
▼ 84%
5 years · compounded
▼ 70%
Revenue fell 32% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA fell 703% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14.8% | ||||
| Net Profit Margin | -19.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Solvista Pharma Private Limited, buy the company report.
Board of directors of Solvista Pharma Private Limited
Solvista Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjana Malhotra | Director | 21 Jan 2016 | 10 Years 9 Months | Current |
| Prerna Sharma | Director | 04 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Solvista Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tiara Life Sciences Limited | ₹21.13 Lakh (FY 2025) | -28.0% | Jalandhar, Punjab, India | |||
| Arch Pharmaceuticals Private Limited | ₹21.12 Lakh (FY 2022) | 36.0% | Gopalganj, Bihar, India | |||
| Solvista Pharma Private Limitedthis company | ₹21.06 Lakh (FY 2023) | -₹4.14 Lakh | -19.7% | -32.0% | Ambala Cantt, Haryana, India | |
| Lan Pharma Chem Private Limited. | ₹20.93 Lakh (FY 2024) | -13.0% | Delhi, India | |||
| Zentiva Healthcare Private Limited | ₹20.9 Lakh (FY 2022) | 36.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Solvista Pharma Private Limited, buy the company report.
Auditor
Solvista Pharma Private Limited is audited by MITTAL GOEL AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MITTAL GOEL AND ASSOCIATES | FY 2017 | 017577N |
Shareholding
The shareholding of Solvista Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Solvista Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Solvista Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Solvista Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Solvista Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAXCS3424J1ZW | Haryana | Active | 16 Jul 2017 |
To see the full GST registrations and return filing status of Solvista Pharma Private Limited, buy the company report.
Recent activity
Solvista Pharma Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Prerna Sharma ceased to be Additional Director on 29 Sep 2023.
AGM
Solvista Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Ceased
Prerna Sharma ceased to be Additional Director.
Ceased
Pankaj Malhotra ceased to be Director.
Appointed
Prerna Sharma was appointed as Director.
Filing
Solvista Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Haryana.
Ceased
Sanjiv Kumar ceased to be Director.
Appointed
Anjana Malhotra was appointed as Director.
Incorporation
21 Jan 2016
Solvista Pharma Private Limited was registered on 21 Jan 2016 with Roc Haryana & aged 10 years 9 months as per MCA records.
Frequently asked questions
Solvista Pharma is an active private limited company based in Ambala Cantt, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 21 January 2016 (10+ years old) and is registered under CIN U24234HR2016PTC057908.
Solvista Pharma has 2 current directors:
- Anjana Malhotra - Director
- Prerna Sharma - Director
The latest financial statements of Solvista Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Solvista Pharma is 06AAXCS3424J1ZW, registered in Haryana.
The CIN (Corporate Identification Number) of Solvista Pharma is U24234HR2016PTC057908. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Solvista Pharma was incorporated on 21 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Solvista Pharma by revenue are Tiara Life Sciences Limited, Arch Pharmaceuticals Private Limited, Lan Pharma Chem Private Limited, Zentiva Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Prerna Sharma ceased to be Additional Director on 29 Sep 2023. Pankaj Malhotra ceased to be Director on 05 Apr 2023. Prerna Sharma was appointed as Director on 04 Apr 2023. Solvista Pharma has 5 board changes on record in total.
Yes, Solvista Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0002214).
Solvista Pharma can be reached through the website solvistapharma.org. Its registered office is in Ambala Cantt, Haryana, India.
The registered office of Solvista Pharma is at 995 Ram Nagar Near Janki Marbels, Ambala Cantt, Haryana, India – 134003.